Analysis

Red Cat Holdings presents investors with a complex puzzle: how can a company reporting explosive quarterly growth simultaneously trigger a...

A significant divestment by a prominent institutional shareholder has raised concerns about Applovin's near-term prospects. The selling activity extends beyond...

Annovis Bio shares experienced a dramatic upward move following the release of encouraging clinical trial data for its Parkinson's disease...

Biotechnology firm Kezar Life Sciences is embarking on a fundamental strategic shift after encountering a significant regulatory obstacle. The U.S....

The platinum market is navigating turbulent waters following an extraordinary price surge that has defined much of the current year....

Skye Bioscience's stock is experiencing another significant downturn this week as the biotechnology firm faces a new class-action lawsuit. The...

Global equity markets demonstrated robust risk appetite throughout October and into early November 2025, providing a favorable backdrop for the...

Investors seeking reliable dividend income are facing new challenges as the Fidelity® High Dividend ETF (FDVV) demonstrates vulnerability during recent...

Travelzoo shares continue to face significant downward pressure, leaving investors questioning whether the decline has a foreseeable end. The company's...

Investor attention turned to Aclaris Therapeutics this week following the company's presentations at the Jefferies Global Healthcare Conference. The biopharmaceutical...